GSK3B and neoplasm: Overall, WES provided valuable insights into the general heterogeneity of EPCs and EPs, revealing at the same discrepancies between the two tumor types, such as exclusive mutations of TP53, NCOR1, CDKN2A, and GSK3B in EPCs and a higher mutational load in EPCs than in EPs.